CORAL GABLES, FL / ACCESSWIRE / June 25, 2015 / Many companies and their publicly traded stock have been hurt this year by the stronger dollar. Even gold prices have shuttered as the US currency has gained value in the exchange markets. Retail, energy, the list goes on and on as far as which sectors have been hit the worst. But it hasn't been all doom and gloom for the entire market. Higher volatility trading like that involved with penny stocks has not felt the brunt of this event. In fact many of these companies and their stocks have seen an increase in trading volume as well as price, over the better part of the last two months. Enviro-Serv Inc (PINKSHEETS: EVSV), US Precious Metals (OTCQB: USPR), and TapImmune, Inc (OTCQB: TPIV) have seen positive price movement and increased share volume during the late spring and early summer season.
Envir-Serv targets highly profitable small service companies in the commercial and residential property maintenance industry. Through its subsidiary Xterminate the company has begun to enter the final stages of closing on a franchise deal with Pestmaster Services for control of the Tampa area operations. In working with the franchise, Enviro-Serv has the opportunity to secure much larger contracts including those with the government because Pestmaster Services is a national Franchisor and a dominant player in the Governmental contracts sector for pest control. There are 21,000 pest control companies in the U.S. and only 70 are approved to bid on Government contracts. Based on this data and several key announcements, EVSV shares have rallied from lows of $0.0002 to highs of $0.0015 in recent weeks.
US Precious Metals has also seen an increase in trading activity most notably over the last few days of trading. The company updated the public on its current drilling program, which is underway on its property in Mexico. Based on finding significant mineralization in each of the cores that have been drilled, these are now being assayed by an independent lab. For mining companies, this tends to be one of the final steps in determining if or when operations can begin. Speculation has sparked more attention on the stock as volume skyrocketed to over 4 million shares traded during the first half of the week. Currently trending in a price channel between 0.14 and 0.16, shares of USPR have seen prices as high as $0.20 this month.
The biotech space is hot right now and TapImmune has found a similar trend. What looks to have started in May, the run that this stock has been on has lasted the better part of the last two months. The stock saw lows of $0.165 on May 6 and since then the stock has rallied to highs of $1.71. This week the Company reported the completion of data analysis from patients treated in a Phase I clinical trial. Dr. Glynn Wilson, TapImmune's CEO stated "We are excited by the Phase I results of our HER2/neu vaccine trial. The potential to treat ~85% of breast cancer patients with this HER2/neu therapeutic approach is significant. The successful completion of this HER2/neu vaccine Phase I study and the robust immune responses detected provides TapImmune with a second Phase II clinical candidate and an expanded clinical pipeline for the treatment of breast and ovarian cancer. It also further validates the technology and the approach developed at Mayo Clinic by Professor Keith Knutson."
ABOUT US:
www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase "StockAlerts" to 63566.
Legal Disclaimer
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.
EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
CONTACT:
Company: EGM FIRM INC.
Contact Email: adam@egmfirm.com
SOURCE: DailyStockReporter.com
